Cita APA

Albiñana, V., Gallardo Vara, E., Rojas-P, I. d. l., Recio-Poveda, L., Aguado Sánchez, T., Canto-Cano, A., . . . Botella, L. M. (2020). Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease.

Citación estilo Chicago

Albiñana, Virginia, et al. Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma From Von Hippel–Lindau Disease. 2020.

Cita MLA

Albiñana, Virginia, et al. Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma From Von Hippel–Lindau Disease. 2020.